Superworth

Iradimed EV/EBIT IRMD

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2015.

Today, Oct 23, 2026
37.7×
10-year median
32.2×
Against its 10-year history
61st
percentile: 0 is its lowest day, 100 its highest
10-year range
5.1× to 316×
Peer median
24.1×

Iradimed's EV/EBIT is 37.7× as of Oct 23, 2026.

That is above its ten-year median of 32.2×, close to the middle of its last ten years.

Over that time it ranged from 5.1× in Feb 2017 to 316× in Feb 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 24.1×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far37.7×36.0×50.7×
202547.6×26.5×47.6×
202430.1×23.5×31.1×
202328.9×22.3×36.1×
202220.9×20.6×75.4×
202169.8×56.2×316×
2020280×17.2×311×
201930.0×25.1×53.0×
201842.5×42.2×130×
201775.2×5.1×75.2×
20167.4×5.9×30.4×
201534.9×32.2×60.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Iradimed's size, closest first, today.

CompanyEV/EBIT
IRMDIradimed37.7×
STAAStaar Surgical57.7×
BVSBioventus26.2×
CDRECadre23.2×
EYENational Vision19.2×
MOVMovado11.8×
LMATLemaitre Vascular22.6×
INSPInspire Medical Systems32.6×
MDXGMimedx51.6×
TCMDTactile Systems Technology13.3×
UFPTUFP Technologies24.9×
Peer median24.1×

Where Iradimed ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Iradimed

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.